Stuart M Weisman, MD
Gastroenterology · Mountain View
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 6
Offices
6 locations · Ridgecrest Regional Hospital · Hshs Medical Group Inc · Otero County Hospital Association
Looking this up.
Hospitals listed: Hshs St Elizabeth'S Hospital. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Weisman’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence G57035 · Current
Licensed to practise in California · since 1986 · expires 2028-02-29 · New York University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Surgery centers they own
- Los Gatos Surgical CenterAmbulatory Surgery Center · Los Gatos, CA2.05% owner since 2015 · accredited by AAAHCAccreditation Renewed6 inspections, 3 with deficiencies · last 2025-04-03
- Los Gatos Surgical CenterSan Jose, CA2.05% owner since 2015 · accredited by AAAHCClosed1 inspection · last 2021-08-10
- Silicon Valley Surgery Center, LPAmbulatory Surgery Center · Campbell, CA1.12% owner since 2012 · accredited by AAAHCAccreditation Renewed4 inspections, 1 with deficiencies · last 2024-09-16
- Silicon Valley Surgery Center, LP - BascomAmbulatory Surgery Center · Campbell, CA1.12% owner since 2012 · accredited by AAAHCAccreditation RenewedNo inspections published
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Hshs St Elizabeth'S HospitalO Fallon, ILAcute Care Hospital · Voluntary non-profit - Church · Has an emergency department · Birthing-friendlyPart of Hospital Sisters Health System, which runs 17 hospitals in 2 statesPatients rate it 4 of 5 · 79% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.198, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.312, Oct 2024 – Sep 2025
See every measure and the patient survey for Hshs St Elizabeth'S Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 1 better, 8 the same, 2 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.198 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.312 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.83 (0 to 1.8) · 915 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.98 (0.66 to 1.29) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 169.11 (117.81 to 220.4) · 58 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 3.8 · 51 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 10.6 · 85 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.8 · 235 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11 · 543 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.5 · 384 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 14.2 · 208 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.9 · 3,070 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.39) · 5,731 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.29 (0.1 to 0.49) · 5,811 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.12 (1.04 to 5.19) · 1,378 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.6 (0.11 to 3.08) · 530 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.81 (1.36 to 4.26) · 1,300 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 12.27 (6.14 to 18.41) · 543 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 3.7 (0.05 to 7.35) · 543 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.59 (0.13 to 3.04) · 288 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.55 (0 to 1.24) · 4,563 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.8 · 29 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.539 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.787 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.26 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 12.7 · 408 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.5 · 1,002 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 14.6 · 255 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 22.6 · 647 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 3.5 · 394 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.2 · 606 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.1 (3.1 to 8.1) · 32 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.8 (6.5 to 14.6) · 32 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.3 · 34 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 12.1 · 76 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 18.7 · 185 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.1 (9.3 to 15.8) · 1,179 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 714 cases | No different | Jan 2024 – Dec 2024 |
What patients said (549 patients answered, 24% of those asked)
| Cleanliness | 1 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 4 |
| Recommend hospital | 5 |
| Room was "always" clean | 59% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 65% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 78% |
| Doctors "always" listened carefully | 81% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 77% |
| Staff "always" explained new medications | 74% |
| Nurses "always" explained things so they could understand | 78% |
| Nurses "always" listened carefully | 80% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 67% |
| "YES", patients would definitely recommend the hospital | 79% |
| Staff "always" explained possible side effects | 55% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
Original Medicare doctor bills
$11,620
Medicare paid this office $11,620 for 44 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 26 | $3,074 | $96 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 12 | $2,506 | $209 |
| Telephone medical discussion with physician, 11-20 minutes | 16 | $2,204 | $85 |
Procedures Medicare counted
| Colonoscopy | 13 | More than 43% of doctors who do this |
| Upper gastrointestinal (GI) endoscopy for acid reflux | 20 | More than 50% of doctors who do this |
Who their Medicare patients are
44 Original Medicare patients in 2024. Average age 75 · Women 39% · Health risk score 0.96. At or below the middle of the specialty; the typical gastroenterology clinician is at 1.42.
Conditions among them: High blood pressure 70% · Cancer 34%.
The office billed $40,330, Medicare allowed $15,724 and paid $11,620; for 96 services of 9 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 44 | 96 | 75 | 0.96 | $40,330 | $11,620 |
| 2023 | 39 | 91 | 75 | 0.97 | $34,900 | $11,456 |
| 2022 | 118 | 201 | 71 | 1.81 | $77,334 | $24,891 |
| 2021 | 199 | 322 | 73 | 1.83 | $124,230 | $36,548 |
| 2020 | 280 | 488 | 71 | 1.97 | $179,024 | $51,970 |
| 2019 | 204 | 434 | 72 | 1.52 | $176,993 | $48,294 |
| 2018 | 181 | 537 | 74 | 1.06 | $184,123 | $55,232 |
| 2017 | 141 | 547 | 74 | 1.12 | $186,206 | $58,810 |
| 2016 | 139 | 489 | 74 | 1.16 | $171,140 | $52,905 |
| 2015 | 129 | 446 | 72 | 0.99 | $169,670 | $51,349 |
| 2014 | 145 | 633 | 73 | 0.84 | $236,391 | $72,105 |
| 2013 | 175 | 650 | 72 | 1.00 | $249,590 | $78,162 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 1 service
| Return visit (30+ min) | 31 | $6,361 | $112 |
2022: 7 services
| Return visit (30+ min) | 47 | $8,326 | $114 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 18 | $3,630 | $202 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 16 | $3,042 | $190 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 12 | $2,243 | $187 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 19 | $1,465 | $77 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 15 | $1,367 | $76 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 12 | $1,215 | $101 |
2021: 9 services
| Telephone medical discussion with physician, 21-30 minutes | 40 | $7,333 | $118 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 24 | $5,093 | $204 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 49 | $3,968 | $75 |
| Diagnostic exam of large bowel using a flexible endoscope | 22 | $3,095 | $141 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 14 | $2,771 | $198 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 28 | $2,512 | $90 |
| Return visit (30+ min) | 13 | $1,638 | $126 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 22 | $1,313 | $57 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 16 | $1,274 | $80 |
2020: 13 services
| Telephone medical discussion with physician, 21-30 minutes | 35 | $4,662 | $101 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 22 | $4,568 | $208 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 29 | $4,504 | $155 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 47 | $4,465 | $81 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 41 | $4,030 | $92 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 41 | $3,558 | $57 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 31 | $3,314 | $107 |
| Diagnostic exam of large bowel using a flexible endoscope | 22 | $3,260 | $148 |
| Biopsy of large bowel using a flexible endoscope | 19 | $2,769 | $146 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 13 | $2,506 | $193 |
| Return visit (30+ min) | 23 | $1,950 | $70 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 19 | $1,782 | $94 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 16 | $502 | $31 |
2019: 9 services
| Return visit (30+ min) | 98 | $17,718 | $86 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 25 | $5,332 | $213 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 20 | $3,952 | $198 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 28 | $3,112 | $104 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 26 | $2,694 | $100 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 17 | $2,586 | $152 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 13 | $2,586 | $199 |
| Diagnostic exam of large bowel using a flexible endoscope | 11 | $1,698 | $142 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 11 | $51 | $4 |
2018: 10 services
| Return visit (30+ min) | 109 | $21,745 | $86 |
| New patient visit (45+ min) | 50 | $6,596 | $132 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 24 | $4,781 | $199 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 20 | $4,158 | $208 |
| Short return visit (20+ min) | 45 | $3,811 | $57 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 28 | $2,973 | $103 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 12 | $2,372 | $198 |
| Diagnostic exam of large bowel using a flexible endoscope | 14 | $2,159 | $154 |
| Biopsy of large bowel using a flexible endoscope | 12 | $1,445 | $120 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 13 | $63 | $5 |
2017: 8 services
| Return visit (30+ min) | 122 | $27,884 | $88 |
| New patient visit (45+ min) | 40 | $5,524 | $138 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 20 | $4,219 | $211 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 31 | $3,851 | $117 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 11 | $2,174 | $198 |
| Short return visit (20+ min) | 17 | $1,504 | $60 |
| Biopsy of large bowel using a flexible endoscope | 12 | $1,388 | $116 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 25 | $121 | $4 |
2016: 5 services
| Return visit (30+ min) | 117 | $26,697 | $88 |
| New patient visit (45+ min) | 52 | $6,956 | $134 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 23 | $5,170 | $225 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 24 | $2,881 | $103 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 13 | $2,714 | $209 |
2015: 7 services
| Return visit (30+ min) | 104 | $20,880 | $88 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 23 | $5,869 | $255 |
| New patient visit (45+ min) | 37 | $4,850 | $131 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 17 | $3,818 | $225 |
| Long return visit (40+ min) | 19 | $2,747 | $114 |
| Diagnostic exam of large bowel using a flexible endoscope | 14 | $2,607 | $186 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 19 | $2,222 | $111 |
2014: 7 services
| Return visit (30+ min) | 124 | $29,895 | $86 |
| Long return visit (40+ min) | 44 | $7,287 | $114 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 21 | $5,333 | $254 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 31 | $4,036 | $119 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 15 | $3,431 | $229 |
| New patient visit (45+ min) | 23 | $3,186 | $139 |
| Diagnostic exam of large bowel using a flexible endoscope | 16 | $2,669 | $167 |
2013: 9 services
| Return visit (30+ min) | 136 | $25,033 | $84 |
| Long return visit (40+ min) | 59 | $10,883 | $110 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 25 | $6,534 | $261 |
| New patient visit (45+ min) | 49 | $5,761 | $118 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 45 | $5,737 | $122 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 20 | $4,654 | $233 |
| Biopsy of large bowel using a flexible endoscope | 24 | $3,637 | $152 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 11 | $2,521 | $229 |
| Diagnostic exam of large bowel using a flexible endoscope | 12 | $2,069 | $172 |
Medicaid work
$4,910 in 2022
Medicaid paid $4,910 for 40 billed services this clinician did in 2022, up to 13 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| DIAGNOSTIC COLONOSCOPY | 12 | $2,324 |
| Diagnostic upper gastrointestinal endoscopy | 13 | $1,368 |
| 1ST HOSPITAL IP/OBS CARE MODERATE MDM 55 MINUTES | 15 | $1,218 |
| 2022 | 40 | 3 | 13 | $4,910 |
| 2020 | 180 | 7 | 23 | $16,693 |
See the largest Medicaid services in earlier years
2020
| 1ST HOSP IP/OBS HIGH 75 | 52 | $5,447 |
| 1ST HOSPITAL IP/OBS CARE MODERATE MDM 55 MINUTES | 32 | $2,910 |
| DIAGNOSTIC COLONOSCOPY | 15 | $2,498 |
| INITIAL OBSERVATION CARE | 16 | $2,105 |
| Diagnostic upper gastrointestinal endoscopy | 33 | $2,099 |
| INITIAL OBSERVATION CARE | 12 | $821 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 20 | $814 |
Drugs they prescribed that Part D paid
$10,579
Pharmacies billed $10,579 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 208) in 2024. At or below the middle of the specialty; the typical gastroenterology clinician is at 0%.
202 generic and fewer than 11 brand-name prescriptions · $10,579 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Esomeprazole Magnesium | 40 | $581 | $15 |
| Cholestyramine | 11 | $327 | $30 |
| Gavilyte-C | 13 | $291 | $22 |
| Omeprazole | 18 | $269 | $15 |
| Pantoprazole | 17 | $160 | $9 |
See all 7 drugs
| Esomeprazole Magnesium | 40 | $581 | $15 |
| Cholestyramine | 11 | $327 | $30 |
| Gavilyte-C | 13 | $291 | $22 |
| Omeprazole | 18 | $269 | $15 |
| Pantoprazole | 17 | $160 | $9 |
| Atorvastatin | 12 | $135 | $11 |
| Trazodone | 19 | $69 | $4 |
Year by year
| 2024 | 208 | 52 | 0% (0) | None | $10,579 |
| 2023 | 231 | 100 | 0% (0) | 8% | $21,016 |
| 2022 | 266 | 154 | 0% (0) | None | $25,372 |
| 2021 | 201 | 85 | 0% (0) | None | $27,324 |
| 2020 | 304 | 120 | 0% (0) | None | $39,515 |
| 2019 | 346 | 98 | None | None | $95,417 |
| 2018 | 391 | 137 | 0% (0) | None | $177,230 |
| 2017 | 492 | 92 | None | 28% | $101,696 |
| 2016 | 439 | 78 | 0% (0) | 22% | $98,556 |
| 2015 | 390 | 81 | None | 31% | $104,997 |
| 2014 | 325 | 69 | 7% (24) | 34% | $169,831 |
| 2013 | 363 | 87 | 6% (20) | 39% | $46,631 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 8 drugs
| Peg3350-Sod Sul-Nacl-Kcl-Asb-C | 12 | $1,230 | $102 |
| Cholestyramine | 16 | $837 | $52 |
| Gavilyte-C | 40 | $798 | $20 |
| Esomeprazole Magnesium | 21 | $318 | $15 |
| Omeprazole | 25 | $285 | $11 |
| Pantoprazole | 20 | $277 | $14 |
| Atorvastatin | 12 | $153 | $13 |
| Trazodone | 16 | $64 | $4 |
2022: 8 drugs
| Suprep | 11 | $1,290 | $117 |
| Cholestyramine | 13 | $898 | $69 |
| Gavilyte-G | 41 | $581 | $14 |
| Peg-3350 and Electrolytes | 34 | $427 | $13 |
| Gavilyte-C | 25 | $404 | $16 |
| Peg 3350-Electrolyte | 12 | $208 | $17 |
| Omeprazole | 13 | $101 | $8 |
| Trazodone | 12 | $48 | $4 |
2021: 6 drugs
| Omeprazole | 14 | $774 | $55 |
| Peg 3350-Electrolyte | 16 | $282 | $18 |
| Gavilyte-G | 14 | $181 | $13 |
| Gavilyte-C | 11 | $152 | $14 |
| Peg-3350 and Electrolytes | 11 | $131 | $12 |
| Atorvastatin | 12 | $127 | $11 |
2020: 9 drugs
| Suprep | 13 | $1,362 | $105 |
| Sulfasalazine Dr | 11 | $509 | $46 |
| Gavilyte-C | 32 | $449 | $14 |
| Gavilyte-G | 26 | $368 | $14 |
| Pantoprazole | 15 | $258 | $17 |
| Metformin | 13 | $216 | $17 |
| Omeprazole | 11 | $191 | $17 |
| Atorvastatin | 12 | $175 | $15 |
| Trazodone | 13 | $96 | $7 |
2019: 8 drugs
| Dexilant | 13 | $9,428 | $725 |
| Moviprep | 17 | $1,830 | $108 |
| Escitalopram | 14 | $251 | $18 |
| Peg 3350-Electrolyte | 15 | $230 | $15 |
| Atorvastatin | 11 | $186 | $17 |
| Tamsulosin | 11 | $117 | $11 |
| Amitriptyline | 12 | $114 | $9 |
| Trazodone | 11 | $88 | $8 |
2018: 11 drugs
| Dexilant | 18 | $9,870 | $548 |
| Mercaptopurine | 14 | $3,505 | $250 |
| Moviprep | 18 | $1,811 | $101 |
| Peg 3350-Electrolyte | 44 | $869 | $20 |
| Escitalopram | 22 | $527 | $24 |
| Sulfasalazine Dr | 11 | $437 | $40 |
| Omeprazole | 14 | $300 | $21 |
| Trazodone | 26 | $274 | $11 |
| Benazepril | 11 | $19 | $2 |
| Hydrochlorothiazide | 11 | $19 | $2 |
| Metoprolol | 11 | $15 | $1 |
2017: 16 drugs
| Dexilant | 22 | $7,134 | $324 |
| Mercaptopurine | 22 | $2,759 | $125 |
| Moviprep | 25 | $2,316 | $93 |
| Balsalazide Disodium | 14 | $2,041 | $146 |
| Lansoprazole | 29 | $1,344 | $46 |
| Suprep | 14 | $1,215 | $87 |
| Cholestyramine | 13 | $1,174 | $90 |
| Celecoxib | 16 | $908 | $57 |
| Trazodone | 29 | $257 | $9 |
| Omeprazole | 18 | $188 | $10 |
| Amitriptyline | 16 | $164 | $10 |
| Escitalopram | 12 | $149 | $12 |
| Metformin | 16 | $77 | $5 |
| Hydrochlorothiazide | 15 | $39 | $3 |
| Benazepril | 11 | $28 | $3 |
| Metoprolol | 11 | $19 | $2 |
2016: 21 drugs
| Lialda | 19 | $16,815 | $885 |
| Balsalazide Disodium | 16 | $3,966 | $248 |
| Mercaptopurine | 24 | $3,924 | $164 |
| Azathioprine | 11 | $1,874 | $170 |
| Esomeprazole Magnesium | 13 | $1,764 | $136 |
| Moviprep | 16 | $1,419 | $89 |
| Suprep | 15 | $1,232 | $82 |
| Lansoprazole | 28 | $1,003 | $36 |
| Celecoxib | 15 | $941 | $63 |
| Cholestyramine | 11 | $676 | $61 |
| Pantoprazole | 15 | $399 | $27 |
| Amitriptyline | 16 | $203 | $13 |
| Atorvastatin | 14 | $191 | $14 |
| Escitalopram | 12 | $180 | $15 |
| Levothyroxine | 14 | $147 | $11 |
| Trazodone | 27 | $110 | $4 |
| Benazepril | 12 | $84 | $7 |
| Simvastatin | 12 | $42 | $4 |
| Metformin | 11 | $26 | $2 |
| Hydrochlorothiazide | 15 | $24 | $2 |
| Metoprolol | 12 | $14 | $1 |
2015: 9 drugs
| Lialda | 18 | $16,073 | $893 |
| Moviprep | 39 | $3,125 | $80 |
| Balsalazide Disodium | 11 | $2,672 | $243 |
| Mercaptopurine | 19 | $2,639 | $139 |
| Lansoprazole | 41 | $2,122 | $52 |
| Amitriptyline | 16 | $180 | $11 |
| Atorvastatin | 14 | $143 | $10 |
| Trazodone | 27 | $124 | $5 |
| Escitalopram | 16 | $116 | $7 |
2014: 10 drugs
| Lialda | 16 | $15,082 | $943 |
| Nexium | 22 | $7,853 | $357 |
| Dexilant | 12 | $2,868 | $239 |
| Mercaptopurine | 16 | $2,740 | $171 |
| Moviprep | 34 | $2,662 | $78 |
| Lansoprazole | 30 | $1,465 | $49 |
| Pantoprazole | 12 | $518 | $43 |
| Escitalopram | 18 | $165 | $9 |
| Acetaminophen-Codeine | 13 | $92 | $7 |
| Trazodone | 13 | $49 | $4 |
2013: 11 drugs
| Nexium | 36 | $17,186 | $477 |
| Lialda | 13 | $7,057 | $543 |
| Moviprep | 35 | $2,509 | $72 |
| Lansoprazole | 18 | $1,967 | $109 |
| Dexilant | 11 | $1,730 | $157 |
| Pantoprazole | 26 | $1,480 | $57 |
| Escitalopram | 17 | $709 | $42 |
| Omeprazole | 23 | $524 | $23 |
| Acetaminophen-Codeine | 20 | $156 | $8 |
| Hydrochlorothiazide | 11 | $62 | $6 |
| Trazodone | 13 | $49 | $4 |
Money from drug and device companies
$21 in 2023
| 2023 | 1 | 1 | None | $21 |
| 2020 | 1 | 1 | None | $18 |
| 2019 | 3 | 5 | None | $18,666 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Ambu | None | $21 | 1 payment
|
See the published payment
| Ambu | Meals · 2023-05-11 | None | $21 |
See earlier years (2020, 2019)
2020: $18
| AbbVie | Humira | $18 | 1 payment
|
2019: $18,666
| Olympus America | Endocapsule | $18,579 | 1 payment
|
| Ferring Pharmaceuticals | Clenpiq | $45 | 2 payments
|
| Pfizer | Xeljanz | $43 | 2 payments
|
Checkups this office reported
3 measures · 2023
Medicare asked this office to report how often certain checkups happened in 2023. This is not a grade for the doctor. A specialist’s patients may not need every screening.
| Asked about smokingPatients asked about tobacco, with help to quit if they smoke | 0%That's few of the people this applied to. | 46 |
| Colon cancer screeningEligible adults who got a colon cancer test | 88%That's most of the people this applied to. | 73 |
| Medications listed in the chartVisits where the current medication list was documented | 57%That's more than half. | 170 |
What the office says it does
Boxes the office ticked on its Medicare worksheet for 2023. Nobody checks these.
- Implementation of medication management practice improvements
- Improved the patient portal
- Uses standard treatment protocols
Professional record
- NPI
- 1619921574
- Licence
- CA G57035California G57035: Current · expires 2028-02-29
- Group
- Ridgecrest Regional Hospital · Hshs Medical Group Inc · Otero County Hospital Association
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 207RG0100X (207RG0100X)
- Mailing address
- 515 South Dr, Suite 12, Mountain View, CA, 94040
- NPI first listed
- 2006-05-22
- NPI last updated
- 2026-02-17
- NPI record certified
- 2026-02-17
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 4705 Montgomery Blvd Ne Ste 201, Albuquerque, NM, 87109 · 4801 Mcmahon Blvd Nw Ste 245, Albuquerque, NM, 87114 · 11104 Parkview Circle Dr Ste 310, Fort Wayne, IN, 46845 · 515 South Dr, Mountain View, CA, 94040
This office lists an electronic records connection.